D-0207-2017 Class III Terminated
FDA drug recall D-0207-2017 was initiated by Zydus Pharmaceuticals USA Inc on Nov 2, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications; 6 month time point The recall status is terminated (terminated Jul 23, 2020). Affected quantity: 16,356 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 28, 2016
- Initiation Date
- Nov 2, 2016
- Termination Date
- Jul 23, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,356 bottles
Product description
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534
Reason for recall
Failed Dissolution Specifications; 6 month time point
Distribution pattern
Nationwide
Code information
a) MS1667 exp 01/2018; M601708, exp 03/2018; b) MS1667, MS1668, MS1669, exp 01/2018; M601515, M601516, exp 03/2018; M602920, M602921, M605399, M602937, M602938, M602939, exp 04/2018; M603988, exp 06/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0207-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026